Safety and Efficacy of CBP-0276 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects
Clinical trial NCT07204639 · RECRUITING
Trial details
- NCT number
- NCT07204639
- Sponsor
- Clarent Biopharma, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2026-07-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.